Agios Pharmaceuticals (NASDAQ:AGIO) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Agios Pharmaceuticals beat estimated earnings by 3.87%, reporting an EPS of $-1.74 versus an estimate of $-1.81.
Revenue was up $832.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.05 which was followed by a 5.7% increase in the share price the next day.
Here's a look at Agios Pharmaceuticals's past performance:
To track all earnings releases for Agios Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
